Hemorrhagic Fever, Ebola - 25 Studies Found Status Study Completed Study Name: Efficacy of Favipiravir Against Ebola (JIKI) Condition: Ebola Virus Disease Date: 2014-12-16 Interventions: Drug: Favipiravir Group A1: Day-0 (inclusion), h0: 2400 mg Withdrawn Study Name: Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) Condition: Ebola Virus Disease Date: 2014-11-21 Interventions: Drug: Best Supportive Care Deh Active, not recruiting Study Name: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) Condition: Prevention of Ebola Infection Date: 2015-07-17 Interventions: Biological: V920 Consistency Lot A Recruiting Study Name: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up Condition: Ebola Virus Disease Date: 2015-04-30 Recruiting Study Name: PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response Condition: Ebola Virus Disease Date: 2017-03-30 <<< Previous